GlassScriptPhysician profile
Malissa Ann Richter
NPI 1609407428
$897.79
in general payments reported to CMS, 2019-2025
16 companies · $450 in 2025
The $450 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $39.93 · 2023: $44.70 · 2024: $363 · 2025: $450.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $855 · Education: $2.82.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $855.04 |
| Education | $2.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axsome Therapeutics, INC. | $248.15 | 2024-2025 | Sunosi |
| Exact Sciences Corporation | $138.72 | 2023-2025 | Cologuard Collection Kit |
| Novo Nordisk INC | $64.24 | 2025 | Wegovy |
| Astellas Pharma US INC | $59.84 | 2024-2025 | Veozah |
| Exeltis, USA INC. | $47.31 | 2023-2025 | Slynd |
| Bayer Healthcare Pharmaceuticals INC. | $44.48 | 2025 | |
| Abbvie INC. | $42.35 | 2024 | |
| Mayne Pharma Commercial LLC | $41.54 | 2025 | |
| Medtronic, INC. | $39.93 | 2021 | |
| Coloplast Corp | $35.48 | 2025 | |
| Acella Pharmaceuticals, LLC | $33.32 | 2024-2025 | NP Thyroid 60 |
| Ibsa Pharma INC. | $30.23 | 2024-2025 | Licart, Tirosint, Flector |
| Antares Pharma, INC. | $20.18 | 2025 | Xyosted |
| Corcept Therapeutics | $18.18 | 2023 | Korlym |
| Sumitomo Pharma America, INC. | $17.62 | 2025 | Gemtesa |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $16.22 | 2024 | Zepbound |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Malissa Richter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.